Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$139,064,022
+$66,732,425 QoQ
Shares Held
2,652,881
+79.9% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#22
of 1,033 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Jun 30, 2026CallValue
$225,406
CallShares
4,300
PutValue
$214,922
PutShares
4,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. GSK ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
This page
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in GSK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,922 | 4,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $139,064,022 | 2,652,881 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $225,406 | 4,300 | Call | Defined | 2026-08-14 | |
| 2025-12-31 | $72,331,597 | 1,474,951 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $6,764,000 | 200,000 | Put | Defined | 2025-02-14 | |
| 2024-03-31 | $23,282,697 | 543,100 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $12,861,000 | 300,000 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $919,088 | 24,800 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $3,775,038 | 106,100 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $227,418,103 | 6,471,773 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $24,598 | 700 | Call | Defined | 2023-05-15 | |
| 2022-09-30 | $72,124,101 | 2,450,700 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $344,331 | 11,700 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $136,021,074 | 4,621,851 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $499,522 | 11,700 | Put | Defined | 2022-08-15 | |
| 2022-06-30 | $104,814,277 | 2,454,999 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,232,319 | 614,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,626,640 | 500,000 | Call | Defined | 2022-02-14 | |
| 2021-12-31 | $15,164,599 | 350,600 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $9,203,827 | 255,000 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||